Skip to content | Change text size
 

Commercialisation Projects 2008

An exiting and innovative part of the Master of Business (Science and Technology degree program is the Commercialisation Project (GSB5000). In this year long project, students work with Monash research scientists on the commercialisation of promising research. The following are some examples.

Lip Kai and Ivy worked with Dr Ben Boyd at the Monash Institute of Pharmaceutical Sciences on a platform technology for extended release versions of existing pharmaceuticals.  The students investigated the market and located likely candidates for reformulation as well as doing an intellectual property search and a competitive analysis.
Francisca, Daniel, and Jean worked with a nutritionist and an intensivist at the Austin Hospital to develop software for detecting and responding to nutritional deficiencies in hospitalised patients.  Malnutrition is a significant problem for many patients, even in a developed country, and can extend their stay in hospital and lead to re-admission shortly after discharge.  The students explored both the technical and the market aspects of the software, including meeting with prospective users and prospective partners.
Cassie and Nick worked with the Deputy Director of the state of the art, robotic Monash Antibody Technology Facility on the development of alternative business plans for the facility.  There results were presented to senior University leaders involved in the oversight of the facility.
Chris and Loretta worked with Dr Amanda Walmsley and her team on the commercialisation of vaccines derived from plants.  This project involved estimating the market for an avian flu vaccine for chickens, particularly in developing countries, and suggesting appropriate partners for vaccine development and manufacture. In their projects, the students do not work in laboratories but when they visit the scientists they are working with they sometimes need to dress up in lab coats to see the scientists' work
Lily and Shiau worked with Dr Gareth Forde on a commercialisation plan for an innovative filtering technology for use in the production of DNA vaccines.  The students visited Dr Forde's laboratory for familiarisation with the technology and spent the first half of their project working on alternative business models for the commercialisation of the technology.  In the second part of the project they identified and contacted a number of potential international business partners.  For their work, Lily and Shiau were two of three winners of the nabCapital Science in Business Award.  In their projects, the students do not work in laboratories but when they visit the scientists they are working with they sometimes need to dress up in lab coats to see the scientists' work
Tom and Keith worked with researchers at the Australian Centre for Blood Diseases to commercialise a platelet aggregation detection device which can be used to diagnose various life-threatening conditions.  The device is based on a new theory of platelet aggregation and is faster and more accurate than existing devices.  The students did a market analysis and an intellectual property search, as well as locating prospective partners for the device.
Adriani and Preeti visiting the laboratory of Dr Sharon Ricardo.  The students worked on the second consecutive year of this project involving potential therapies for premature infants with under-developed organs.  In particular, the students worked on the early stage of clinical trial design.
Ben and Tim worked with a team of scientists led by Professor Christina Mitchell on potential therapies for a muscle wasting disease, Facioscapulohumeral Muscular Dystrophy.  The research was funded by the foundation established by prominent investment banker, Mr Bill Moss, with whom the students interacted during the course of the project.